SERTRALINE HYDROCHLORIDE
NDC 42708-092, SERTRALINE HYDROCHLORIDE, tablet, film coated, from QPharma, Inc..
- Product NDC
- 42708-092
- Status
- Listed
- Labeler
- QPharma, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202825
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42708-092 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SERTRALINE HYDROCHLORIDE50 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42708-092-30 | 42708009230 | 30 TABLET, FILM COATED in 1 BOTTLE (42708-092-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/dc97a895-8c2f-4891-85f3-7f45e2396140
Use it
Look up 42708-092 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42708-092 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42708-092. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.